Hypomethylation of TMPRSS4 may serve as a diagnostic indicator for early-stage NSCLC in both BAL and plasma samples, broadening the clinical utility of liquid biopsy-based assays [171]. This evidence concerns the gene TMPRSS4 and non-small cell lung carcinoma.